ZA893892B - Therapeutic products - Google Patents

Therapeutic products

Info

Publication number
ZA893892B
ZA893892B ZA893892A ZA893892A ZA893892B ZA 893892 B ZA893892 B ZA 893892B ZA 893892 A ZA893892 A ZA 893892A ZA 893892 A ZA893892 A ZA 893892A ZA 893892 B ZA893892 B ZA 893892B
Authority
ZA
South Africa
Prior art keywords
oestrogen
product
therapeutic products
manufacture
pharmaceutical composition
Prior art date
Application number
ZA893892A
Other languages
English (en)
Inventor
Michael Dukes
Dukes Michael
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of ZA893892B publication Critical patent/ZA893892B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA893892A 1988-06-06 1989-05-23 Therapeutic products ZA893892B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888813353A GB8813353D0 (en) 1988-06-06 1988-06-06 Therapeutic product

Publications (1)

Publication Number Publication Date
ZA893892B true ZA893892B (en) 1990-02-28

Family

ID=10638154

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA893892A ZA893892B (en) 1988-06-06 1989-05-23 Therapeutic products

Country Status (17)

Country Link
US (1) US5183814A (de)
EP (1) EP0346014B1 (de)
JP (1) JP2918042B2 (de)
AT (1) ATE109351T1 (de)
AU (1) AU622184B2 (de)
CA (1) CA1337591C (de)
DE (1) DE68917219T2 (de)
DK (1) DK175740B1 (de)
ES (1) ES2057124T3 (de)
FI (1) FI892762A7 (de)
GB (1) GB8813353D0 (de)
IE (1) IE64368B1 (de)
IL (1) IL90410A (de)
NO (1) NO892293L (de)
NZ (1) NZ229392A (de)
PT (1) PT90764B (de)
ZA (1) ZA893892B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9301562A (nl) * 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
US5407947A (en) * 1993-11-05 1995-04-18 Eli Lilly And Company Methods for inhibiting bone loss using pyrolidine and piperidine substituted benzopyrans
US5612317A (en) * 1994-08-04 1997-03-18 Holick; Michael F. Method for delivering estrogen
ZA9510926B (en) * 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
DE19510862A1 (de) * 1995-03-16 1996-09-19 Schering Ag Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5965551A (en) * 1996-02-21 1999-10-12 North Carolina State University Method of treating alopecia
DE19807791A1 (de) * 1998-02-19 1999-08-26 Schering Ag Kombinationspräparat aus Östrogen und Antiöstrogen
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
US7989436B2 (en) * 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
DE10039199A1 (de) * 2000-08-10 2002-02-21 Schering Ag Kombinationspräparate aus einem ERß selektiven Estrogen und einem SERM oder Antiestrogen
EP1287817A1 (de) * 2001-08-31 2003-03-05 Pantarhei Bioscience B.V. Verfahren und intravaginales Arzneiverabreichungsvorrichtung zur Behandlung von uterinem Myom
PL367624A1 (en) * 2001-07-07 2005-03-07 Astrazeneca Ab Pharmaceutical formulation for the intramuscular administration of fulvestrant
GB0116620D0 (en) * 2001-07-07 2001-08-29 Astrazeneca Ab Formulation
EP1411922A1 (de) 2001-07-31 2004-04-28 Pfizer Products Inc. Pharmazeutische zusammensetzungen, kits und methoden enthaltend kombinationen von oestrog agonisten/antagonisten, oestrogenen und progestinen
WO2003017974A1 (en) * 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Method of treating benign gynaecological disorders and a pharmaceutical kit for use in such method
DE10159217A1 (de) 2001-11-27 2003-06-05 Schering Ag 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
GB0302572D0 (en) * 2003-02-05 2003-03-12 Astrazeneca Ab Method of treatment
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
AU2004281551B2 (en) * 2003-10-17 2009-10-29 Intervet International B.V. Compositions for controlling parasites comprising a combination of abamectin and ivermectin
EP1853272A1 (de) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Zusammensetzungen aus unkonjugierten östrogenen und anwendungsverfahren dafür
SG165404A1 (en) * 2005-09-26 2010-10-28 Hospira Australia Pty Ltd Fulvestrant formulation
DE102005057224A1 (de) 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
EP2048126A1 (de) 2007-10-11 2009-04-15 Bayer Schering Pharma AG Benzocycloheptanderivate als selektiv wirksame Estrogene
EP2258375A1 (de) 2009-06-04 2010-12-08 Bayer Schering Pharma Aktiengesellschaft 17B-alkyl-17alpha-oxy-estratriene
DE102010030538A1 (de) 2010-06-25 2011-12-29 Bayer Schering Pharma Aktiengesellschaft 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
EP2711010B1 (de) 2011-05-20 2018-10-31 Capital, Business Y Gestión De Finanzas, S.L Pharmazeutische zusammensetzung
DE102011087987A1 (de) 2011-12-08 2013-06-13 Bayer Intellectual Property Gmbh 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
CN102600073B (zh) * 2012-03-31 2014-01-01 莱普德制药有限公司 以乳酸酯为基础的氟维司群或其衍生物油性制剂及其制备方法
US9271990B2 (en) * 2014-02-14 2016-03-01 Fresenius Kabi Usa, Llc Fulvestrant formulations
RU2684330C1 (ru) * 2018-02-02 2019-04-08 Закрытое Акционерное Общество "Биокад" Композиции фулвестранта

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311678D0 (en) * 1983-04-28 1983-06-02 Ici Plc Phenol derivatives
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency

Also Published As

Publication number Publication date
FI892762L (fi) 1989-12-07
ATE109351T1 (de) 1994-08-15
IE891670L (en) 1989-12-06
DK273489D0 (da) 1989-06-02
PT90764B (pt) 1994-10-31
FI892762A7 (fi) 1989-12-07
IL90410A (en) 1994-07-31
JP2918042B2 (ja) 1999-07-12
GB8813353D0 (en) 1988-07-13
PT90764A (pt) 1989-12-29
FI892762A0 (fi) 1989-06-06
NO892293D0 (no) 1989-06-05
US5183814A (en) 1993-02-02
DK175740B1 (da) 2005-02-07
NZ229392A (en) 1992-01-29
EP0346014A1 (de) 1989-12-13
EP0346014B1 (de) 1994-08-03
CA1337591C (en) 1995-11-21
AU622184B2 (en) 1992-04-02
NO892293L (no) 1989-12-07
ES2057124T3 (es) 1994-10-16
DK273489A (da) 1989-12-07
JPH0242024A (ja) 1990-02-13
IE64368B1 (en) 1995-07-26
DE68917219D1 (de) 1994-09-08
AU3592389A (en) 1989-12-07
DE68917219T2 (de) 1994-12-15

Similar Documents

Publication Publication Date Title
ZA893892B (en) Therapeutic products
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
HUT70157A (en) Imidazolylalcenoic acids, pharmaceutical compositions containing them, and process for producing them, and use of them for preparing medicaments
HUT59000A (en) Process for producing pharmaceutical preparations containing 4-phenyl-1,2,3,4-tetrahydro-1-naphtalinamine-derivatives
HUT52526A (en) Process for producing enzyme-inhibiting dipeptide-urea derivatives and pharmaceutical compositions containing them
HUT48900A (en) Process for producing phosphoruus-containing squalene-synthetase inhibitores and pharmaceutical compositions containing them
HUT53644A (en) Process for producing pharmaceutical nukleozides and pharmaceutical compositions containing them
GB2148839B (en) Product capsuling process and plant, particularly for pharmaceutical products
GR3020098T3 (en) 11-Beta-aryl-4-estrene, method for its production and its use as a medicine
YU156788A (en) Process for producing matrix for releasing and/or dosing healing active material
UA19156A (uk) Спосіб одержаhhя амідіhів або їх фармацевтичhо прийhятhих солей
HUT63577A (en) Process for producing pharmaceutical compositions suitable for intranasal treatment and sprayer for administering such compositions
ZA877901B (en) Active compounds for use in the treatment of tumors
HUT44524A (en) Process for producing 1,3-thiazolyl- or 1,3,4-thiadiazolyl- derivatives and pharmaceutical compositions containing them
HU893631D0 (en) Process for producing 1,1-dioxo-cephem-4-carbothiolic acid derivatives and pharmaceutical prepartives containing them as active substance
HUT52517A (en) Process for producing antiseptic nukleozides and pharmaceutical compositions containing them
HUT64548A (en) Method for producing new phosphocipid derivatives and pharmaceutical preparatives containing them
HRP960081B1 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use in the production of pharmaceutical preparations and medicaments containing them
EP0173145A3 (en) Reduction of the toxic effects caused by anthraquinone drugs
HUT52071A (en) Process for producing 1-amino-alkyl-3-oxy-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-one derivatives and pharmaceutical compositions containing them as active components
IE831131L (en) Use of a cholecalciferol derivative
HUT45261A (en) Process for producing 7-oxo-4-thia-1-aza-bicyclo/3.2.0/-hept-2-ene derivatives and pharmaceutical compositions containing them
HU202557B (en) Process for producing sialinic acid-octapeptide and pharmaceutical compositions containing them
HUT51626A (en) Process for producing 5-substituted amino-8-phenyl or substituted phenyl-3h,6h-1,4,5a,8a-tetraaza-ceanaphthylene-3-ones and pharmaceutical preparations containing these compounds
AU637419B2 (en) Application of a carbothioamine 1-oxide to the preparation of medicinal products for the treatment of coronary insufficiency